Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
277 results found
2017 ∙ Haute Autorité de Santé
Minutes of the CTV meeting - November 21st 2017
Agenda & Minutes Europe France Pneumococcal disease Influenza Diphtheria Tetanus Pertussis Poliomyelitis
Download:
2017 ∙ WHO AFRO
Recommendation to replace PCV-10 by PCV-13 in routine immunization of children under the age of 12
Recommendation Africa Zambia Pneumococcal disease
Download:
2017 ∙ IVAC
The Evidence Base for Pneumococcal Conjugate Vaccines (PCVs)
Pneumococcal disease
Download:
2016 ∙ Saokaew, S. Rayanakorn, A. Wu, D. B. C. Chaiyakunapruk, N.
Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review
Newborn Children Adolescents Low and Middle Income Countries Pneumococcal disease Economic aspects
Rating:
Not applicable
2016 ∙ Segal, N. Greenberg, D. Dagan, R. Ben-Shimol, S.
Disparities in PCV impact between different ethnic populations cohabiting in the same region: A systematic review of the literature
All age groups Pneumococcal disease Efficacy/effectiveness Ethical issues
Rating:
Critically low
2016 ∙ Gibson, E. Begum, N. Sigmundsson, B. Sackeyfio, A. Hackett, J. Rajaram, S.
Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review
All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Human papillomavirus (HPV) Hepatitis B Varicella Economic aspects
Rating:
Not applicable
2016 ∙ Remschmidt, C. Harder, T. Wichmann, O. Bogdan, C. Falkenhorst, G.
Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: A systematic review
Adults Older adults Pneumococcal disease Efficacy/effectiveness Safety
Rating:
High
2016 ∙ Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.
Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
Adolescents Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2016 ∙ Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.
Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2016 ∙ DeAntonio, R. Yarzabal, J. P. Cruz, J. P. Schmidt, J. E. Kleijnen, J.
Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review
Newborn Children Low and Middle Income Countries Haemophilus influenzae type B Pneumococcal disease Coverage
Rating:
Not applicable
Loading...